Ursula Fearon

Prof. Ursula Fearon


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2017 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
Ali MobasheriAli Mobasheri
Ali Mobasheri
MRMargaret P. Rayman
Margaret P. Rayman
OGOreste Gualillo
Oreste Gualillo
JSJérémie Sellam
Jérémie Sellam
PKPeter van der Kraan
Peter van der Kraan
UFUrsula Fearon
Ursula Fearon

1 September 2018 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
TMTrudy McGarry
Trudy McGarry
MBMonika Biniecka
Monika Biniecka
DVDouglas Veale
Douglas Veale
UFUrsula Fearon
Ursula Fearon

1 June 2018 in The Lancet
Verified
Journal Article
Closed access
DVDouglas Veale
Douglas Veale
UFUrsula Fearon
Ursula Fearon

26 May 2016 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
UFUrsula Fearon
Ursula Fearon
MCMary Canavan
Mary Canavan
MBMonika Biniecka
Monika Biniecka
DVDouglas Veale
Douglas Veale

17 July 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
SRSimon Rauber
Simon Rauber
MLMarkus Luber
Markus Luber
SWStefanie Weber
Stefanie Weber
LMLisa Maul
Lisa Maul
ASAlina Soare
Alina Soare
ARAndreas Ramming
Andreas Ramming

1 July 2010 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
CNC T Ng
C T Ng
MBM Biniecka
M Biniecka
AKA Kennedy
A Kennedy
JMJ McCormick
J McCormick
OFOliver FitzGerald
Oliver FitzGerald
DVDouglas Veale
Douglas Veale
Introduction Hypoxia is a microenvironmental feature in the inflamed joint, which promotes survival advantage for cells. The aim of this study was to examine the relationship of partial oxygen pressure in the synovial tissue (tPO2) in patients with inflammatory arthritis with macroscopic/microscopic inflammation and local levels of proinflammatory mediators. Methods Patients with inflammatory arthritis underwent full clinical assessment and video arthroscopy to quantify macroscopic synovitis and measure synovial tPO2 under direct visualisation. Cell specific markers (CD3 (T cells), CD68 (macrophages), Ki67 (cell proliferation) and terminal deoxynucleotidyl transferase dUTP nick end labelling (cell apoptosis)) were quantified by immunohistology. In vitro migration was assessed in primary and normal synoviocytes (synovial fibroblast cells (SFCs)) using a wound repair scratch assay. Levels of tumour necrosis factor α (TNFα), interleukin 1β (IL1β), interferon γ (IFNγ), IL6, macrophage inflammatory protein 3α (MIP3α) and IL8 were quantified, in matched serum and synovial fluid, by multiplex cytokine assay and ELISA. Results The tPO2 was 22.5 (range 3.2–54.1) mm Hg and correlated inversely with macroscopic synovitis (r=−0.421, p=0.02), sublining CD3 cells (−0.611, p<0.01) and sublining CD68 cells (r=−0.615, p<0.001). No relationship with cell proliferation or apoptosis was found. Primary and normal SFCs exposed to 1% and 3% oxygen (reflecting the median tPO2 in vivo) induced cell migration. This was coupled with significantly higher levels of synovial fluid tumour necrosis factor α (TNFα), IL1β, IFNγ and MIP3α in patients with tPO2 <20 mm Hg (all p values <0.05). Conclusions This is the first study to show a direct in vivo correlation between synovial tPO2, inflammation and cell migration, thus it is proposed that hypoxia is a possible primary driver of inflammatory processes in the arthritic joint.